PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC

• L. Schaff,
• M. Lobbous,
• D. Carlow,
• L. DeAngelis,
• L. B. Nabors,
• C. Grommes

Affiliations

L. Schaff

1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY

M. Lobbous

2 Neurology, University of Alabama at Birmingham, Birmingham, AL

D. Carlow

3 Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, United States of America

L. DeAngelis

1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY

L. B. Nabors

2 Neurology, University of Alabama at Birmingham, Birmingham, AL

C. Grommes

1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY